Reuters logo
BRIEF-Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for multiple myeloma treatment
April 12, 2017 / 11:35 AM / 7 months ago

BRIEF-Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for multiple myeloma treatment

April 12 (Reuters) - Active Biotech Ab

* Reg-Active biotech: fda grants orphan drug designation for tasquinimod for the treatment of multiple myeloma Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below